Revance Therapeutics Inc
RVNC
Common Stock
$5.72
Sector: Health Care
Industry: Pharmaceuticals
Sub-Industry: Pharmaceuticals
|
|
|
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
(Diluted) Earnings Per Share | -$4.17 | -$4.86 | -$3.67 | -$3.94 | -$4.01 |
Sales/Revenue | $77.80 M | $15.33 M | $0.41 M | $3.73 M | $0.26 M |
Sales Growth | 407.65% | 3610.65% | -88.92% | 1323.28% | 0.00% |
Gross Margin | +44.39 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | -$281.31 M | -$282.09 M | -$159.43 M | -$142.57 M | -$120.59 M |
Net Income Growth | 0.28% | -76.94% | -11.83% | -18.23% | 0.00% |
Net Margin | -361.59 | 0.00 | 0.00 | 0.00 | 0.00 |
EBITDA | -$254.82 M | -$247.83 M | -$161.55 M | -$140.91 M | -$116.03 M |
Cost of Goods Sold (incl D&A) | $43.26 M | $15.02 M | $0.00 M | $0.00 M | $0.00 M |
Cost of Goods Sold (excl D&A) | $23.41 M | $4.77 M | $0.00 M | $0.00 M | $0.00 M |
Cost of Goods Growth | 188.04% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | $114.48 M | $112.54 M | $100.82 M | $92.50 M | $80.36 M |
Other SG&A Expenses | $0.00 M | $145.84 M | $61.14 M | $52.14 M | $35.93 M |
Interest Expense | $6.27 M | $15.15 M | $0.00 M | $0.04 M | $0.46 M |
Income Tax | $0.00 M | -$2.62 M | $0.00 M | $3.00 M | $0.00 M |
2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | |
---|---|---|---|---|
(Diluted) Earnings Per Share | -$0.94 | -$0.93 | -$1.10 | -$1.07 |
Sales/Revenue | $25.26 M | $25.95 M | $19.75 M | $18.80 M |
Sales Growth | -2.66% | 31.43% | 5.00% | 41.39% |
Gross Margin | +44.39 | 0.00 | 0.00 | 0.00 |
Net Income | -$64.34 M | -$63.10 M | -$74.38 M | -$72.20 M |
Net Income Growth | -1.97% | 15.16% | -3.02% | -0.78% |
Net Margin | -361.59 | 0.00 | 0.00 | 0.00 |
EBITDA | -$56.85 M | -$56.19 M | -$67.57 M | -$65.29 M |
Cost of Goods Sold (incl D&A) | $13.27 M | $13.30 M | $11.04 M | $10.47 M |
Cost of Goods Sold (excl D&A) | $7.89 M | $7.88 M | $5.89 M | $5.43 M |
Cost of Goods Growth | -0.23% | 20.51% | 5.42% | 23.78% |
Research & Development | $30.27 M | $29.05 M | $29.66 M | $28.99 M |
Other SG&A Expenses | $0.00 M | $0.00 M | $51.77 M | $49.68 M |
Interest Expense | $1.93 M | $1.57 M | $1.57 M | $1.57 M |
Income Tax | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Net Property and Plant Equipment | $69.00 M | $47.13 M | $41.29 M | $14.45 M | $9.25 M |
Cash and Short-Term Investment | $225.07 M | $436.51 M | $290.12 M | $175.81 M | $282.90 M |
Cash and Short-Term Investment Growth | -48.44% | 50.46% | 65.01% | -37.85% | 0.00% |
Long Term Debt | $319.77 M | $207.67 M | $25.87 M | $0.00 M | $0.00 M |
Net Total Accounts Receivable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Receiveable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Payable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Assets | $531.16 M | $720.22 M | $340.29 M | $226.35 M | $295.70 M |
Total Assets Growth | -26.25% | 111.65% | 50.34% | -23.45% | 0.00% |
Inventories | $10.15 M | $5.88 M | $0.00 M | $0.00 M | $0.00 M |
Finished Goods | $10.15 M | $5.88 M | $0.00 M | $0.00 M | $0.00 M |
Short Term Debt | $4.75 M | $4.44 M | $6.42 M | $0.00 M | $1.87 M |
Total Liabilities | $462.69 M | $345.93 M | $114.80 M | $80.73 M | $26.85 M |
2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | |
---|---|---|---|---|---|
Net Property and Plant Equipment | $66.55 M | $69.00 M | $67.56 M | $67.43 M | $49.55 M |
Cash and Short-Term Investment | $262.59 M | $225.07 M | $273.68 M | $336.30 M | $386.81 M |
Cash and Short-Term Investment Growth | 16.67% | -17.76% | -18.62% | -13.06% | 0.00% |
Long Term Debt | $468.79 M | $319.77 M | $320.79 M | $321.28 M | $305.90 M |
Net Total Accounts Receivable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Receiveable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Payable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Assets | $639.55 M | $531.16 M | $581.83 M | $640.88 M | $675.95 M |
Total Assets Growth | 20.40% | -8.71% | -9.21% | -5.19% | 0.00% |
Inventories | $10.66 M | $10.15 M | $10.19 M | $5.07 M | $5.63 M |
Finished Goods | $10.66 M | $10.15 M | $10.19 M | $5.07 M | $5.63 M |
Short Term Debt | $23.69 M | $4.75 M | $4.83 M | $5.65 M | $4.47 M |
Total Liabilities | $614.01 M | $462.69 M | $461.67 M | $454.64 M | $431.70 M |
Expiration Date | Call To Put Ratio | Open Money on Chain |
---|---|---|
2025-01-17 | 4.58 | -$3.13 M |
Quarter | Amount | Yield |
---|
|
|